| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AMH
|
anti-Mullerian hormone
|
|
APOA1
|
apolipoprotein A-I
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARAP1
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C17ORF97
|
chromosome 17 open reading frame 97
|
|
CA2
|
carbonic anhydrase II
|
|
CALB2
|
calbindin 2
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD274
|
CD274 molecule
|
|
CD82
|
CD82 molecule
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM7
|
carcinoembryonic antigen-related cell adhesion molecule 7
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)
|
|
DCTN6
|
dynactin 6
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DHCR24
|
24-dehydrocholesterol reductase
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EPHA1
|
EPH receptor A1
|
|
EPHB3
|
EPH receptor B3
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETV6
|
ets variant 6
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FLNA
|
filamin A, alpha
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
GALNT6
|
polypeptide N-acetylgalactosaminyltransferase 6
|
|
GATA6
|
GATA binding protein 6
|
|
GPX3
|
glutathione peroxidase 3
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC7
|
histone deacetylase 7
|
|
HNF1B
|
HNF1 homeobox B
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA2
|
heat shock 70kDa protein 2
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IGF2
|
insulin-like growth factor 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT20
|
keratin 20, type I
|
|
LIMS2
|
LIM and senescent cell antigen-like domains 2
|
|
LIMS3
|
LIM and senescent cell antigen-like domains 3
|
|
LIMS3L
|
LIM and senescent cell antigen-like domains 3-like
|
|
LPAR3
|
lysophosphatidic acid receptor 3
|
|
MAGEA1
|
melanoma antigen family A1
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGED4
|
melanoma antigen family D4
|
|
MAGED4B
|
melanoma antigen family D4B
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MLH1
|
mutL homolog 1
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NEU1
|
sialidase 1 (lysosomal sialidase)
|
|
NEURL1
|
neuralized E3 ubiquitin protein ligase 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
|
P2RX5
|
purinergic receptor P2X, ligand gated ion channel, 5
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAX8
|
paired box 8
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDCD5
|
programmed cell death 5
|
|
PGR
|
progesterone receptor
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PROM1
|
prominin 1
|
|
PSD4
|
pleckstrin and Sec7 domain containing 4
|
|
PSG2
|
pregnancy specific beta-1-glycoprotein 2
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
SCO2
|
SCO2 cytochrome c oxidase assembly protein
|
|
SHBG
|
sex hormone-binding globulin
|
|
SIRT1
|
sirtuin 1
|
|
SLC22A16
|
solute carrier family 22 (organic cation/carnitine transporter), member 16
|
|
SLC25A20
|
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20
|
|
SOX7
|
SRY (sex determining region Y)-box 7
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
SYP
|
synaptophysin
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TMED7
|
transmembrane emp24 protein transport domain containing 7
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
|
TNXB
|
tenascin XB
|
|
TP53
|
tumor protein p53
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TYMP
|
thymidine phosphorylase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
